Literature DB >> 809553

A method for the preparation and quality control of 68Ga radiopharmaceuticals.

D J Hnatowich.   

Abstract

Gallium-68 (T 1/2 68 min) is a convenient label for radiopharmaceuticals designed for use with positron detection devices; the radionuclide is a generator produce obtained from its parent 68Ge (T 1/2 287 days). The labeling procedure itself is simple since gallium forms complexes without the use of reducing agents. However, 68Ga is present in the generator eluant as the gallium-EDTA chelate and must be separated from EDTA prior to its use as a label. A rapid and efficient method for achieving this separation and for preparing 68Ga-labeled compounds for human use has been developed. Paper chromatography is employed to determine the amount of each major gallium species present in preparations of two gallium complexes; 68Ga-adenosine triphosphate and 68Ga-citrate.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 809553

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

1.  68Ga-labelled DOTA-derivatised peptide ligands.

Authors:  G-J Meyer; H Mäcke; J Schuhmacher; W H Knapp; M Hofmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-17       Impact factor: 9.236

2.  Simple, fast preparation of gallium-68-labelled human serum albumin microspheres.

Authors:  J P Yvert; B Mazière; M Verhas; D Comar
Journal:  Eur J Nucl Med       Date:  1979-04-01

3.  Very high specific activity ⁶⁶/⁶⁸Ga from zinc targets for PET.

Authors:  J W Engle; V Lopez-Rodriguez; R E Gaspar-Carcamo; H F Valdovinos; M Valle-Gonzalez; F Trejo-Ballado; G W Severin; T E Barnhart; R J Nickles; M A Avila-Rodriguez
Journal:  Appl Radiat Isot       Date:  2012-03-28       Impact factor: 1.513

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.